Literature DB >> 32799579

PROMOTING SAFE AND EFFECTIVE USE OF AEROSOL DEVICES IN COVID-19:RISKS AND SUGGESTIONS FOR VIRAL TRANSMISSION.

Arzu Ari1.   

Abstract

Entities:  

Keywords:  Aerosols; Covid-19; and viral transmission; dry powder-inhalers; metered-dose inhalers; nebulizers; soft-mist inhalers

Mesh：

Substances：

Year:  2020        PMID： 32799579     DOI： 10.1080/17425247.2020.1811225

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  8 in total

Review 1.  WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.

Authors:  Philip W Rouadi; Samar A Idriss; Jean Bousquet; Tanya M Laidlaw; Cecilio R Azar; Mona S Al-Ahmad; Anahi Yañez; Maryam Ali Y Al-Nesf; Talal M Nsouli; Sami L Bahna; Eliane Abou-Jaoude; Fares H Zaitoun; Usamah M Hadi; Peter W Hellings; Glenis K Scadding; Peter K Smith; Mario Morais-Almeida; René Maximiliano Gómez; Sandra N Gonzalez Diaz; Ludger Klimek; Georges S Juvelekian; Moussa A Riachy; Giorgio Walter Canonica; David Peden; Gary W K Wong; James Sublett; Jonathan A Bernstein; Lianglu Wang; Luciana K Tanno; Manana Chikhladze; Michael Levin; Yoon-Seok Chang; Bryan L Martin; Luis Caraballo; Adnan Custovic; Jose Antonio Ortego-Martell; Olivia J Ly Lesslar; Erika Jensen-Jarolim; Motohiro Ebisawa; Alessandro Fiocchi; Ignacio J Ansotegui
Journal:  World Allergy Organ J       Date:  2022-05-14       Impact factor: 5.516

2.  Risk of Transmitting Coronavirus Disease 2019 During Nebulizer Treatment: A Systematic Review.

Authors:  Karen M Goldstein; Kamrouz Ghadimi; Harry Mystakelis; Yuanyuan Kong; Tongtong Meng; Sarah Cantrell; Megan Von Isenburg; Adelaide Gordon; Belinda Ear; Jennifer M Gierisch; John W Williams
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2021-04-21       Impact factor: 3.440

Review 3.  Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems.

Authors:  Ahmed A H Abdellatif; Hesham M Tawfeek; Ahmed Abdelfattah; Gaber El-Saber Batiha; Helal F Hetta
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-19       Impact factor: 3.981

Review 4.  How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review.

Authors:  Arzu Ari; Gerald B Moody
Journal:  Can J Respir Ther       Date:  2021-03-01

5.  Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation.

Authors:  Mary Joyce; James A McGrath; Marc Mac Giolla Eain; Andrew O'Sullivan; Miriam Byrne; Ronan MacLoughlin
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

Review 6.  Nasally inhaled therapeutics and vaccination for COVID-19: Developments and challenges.

Authors:  Jinxiang Xi; Lameng Ray Lei; William Zouzas; Xiuhua April Si
Journal:  MedComm (2020)       Date:  2021-12-14

7.  Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis.

Authors:  Ayca Yildiz Pekoz; Ozlem Akbal Dagistan; Hanan Fael; Meltem Culha; Aybige Erturk; Nur Sena Basarir; Gokben Sahin; Muge Serhatli; Gamze Cakirca; Saban Tekin; Leyla Semiha Sen; Mustafa Sevim; Lutfiye Mulazimoglu Durmusoglu; Berrak C Yegen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 8.  Asthma and COVID-19: What do we know now.

Authors:  Alexzandra Hughes-Visentin; Anthea B Mahesan Paul
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-10-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.